Corvus Pharmaceuticals (NASDAQ: CRVS) shares more than doubled on Jan. 20 after announcing positive Phase 1…
Asian markets ended Friday on a mixed note. While strong global economic data provided some support,…
The Indian rupee continued its strong slump against the US dollar this week, reaching a fresh…
by admin
-
-
The global IPO market remained broadly flat in the first half of 2025, with 539 deals…
-
Donald Trump’s administration is preparing to sign an executive order that could radically transform the US…
-
The IAG share price continued its strong trajectory this week as investors reacted to encouraging earnings…
-
The FTSE 100 Index is hovering near its all-time high as investors wait for the upcoming…
-
The USD/JPY exchange rate rebounded to its highest level since April 3, following a rise in…
-
The EasyJet share price faced turbulence on Thursday after the company published weaker-than-expected earnings. It plunged…
-
Swiss pharmaceutical giant Novartis has raised its full-year earnings forecast, citing robust revenue growth from key…